<?xml version="1.0" encoding="UTF-8" ?><dbgapss xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="dbgapssws.1.0.xsd"><Study uid="7087" whole_study_id="7087" phs="000369" v="1" p="1" createDate="2011-06-16T09:38:50-05:00" modDate="2021-07-13T22:01:27-05:00" maxParentChildStudyModDate="2021-07-13T22:01:27-05:00" handle="BreastCarcinoma_Meyerson" num_participants="110"><StudyInfo accession="phs000369.v1.p1" parentAccession="phs000369.v1.p1"><BioProject id="PRJNA75977" entrez_id="75977" type="bp_admin_access"/><BioProject id="PRJNA75979" entrez_id="75979" type="bp_data_submission"/><StudyNameEntrez>Genomic Sequencing of Breast Carcinoma</StudyNameEntrez><StudyTypes2 calculated="Yes"><StudyType21 name="phenotype_data" chosen="Yes"/><StudyType21 name="analysis" chosen="Yes"/><StudyType21 name="individual_sequencing" chosen="Yes"><StudyType22 name="ncbi_for_sequence"/></StudyType21><StudyType21 name="supporting_documents" chosen="No"/><StudyType21 name="images" chosen="No"/><StudyType21 name="molecular" chosen="Yes"/><StudyType21 name="subject_samples" chosen="Yes"/><StudyType21 name="links_to_ncbi_dbs" chosen="No"/><StudyType21 name="other_general" chosen="No"/></StudyTypes2><StudyTypes><StudyType>phenotype_data</StudyType><StudyType>genotype_data</StudyType><StudyType>analysis</StudyType><StudyType>sra</StudyType></StudyTypes><SraStorages><SraStorage location="NCBI"/></SraStorages></StudyInfo><Authority><ICs><IC id="4" name="NCI" is_funding_ic="false" is_admin_ic="true" primary="true"/></ICs><Persons><Person nedid="MMEYERSON01" aid="2" auth="eRA" login="MMEYERSON01" fname="Matthew" mname="L" lname="Meyerson" email="matthew_meyerson@dfci.harvard.edu"><Role>PI</Role><Organization>HARVARD MEDICAL SCHOOLBROAD INSTITUTE, INC.DANA-FARBER CANCER INST</Organization></Person><Person nedid="0012988688" aid="1" auth="cit" login="popovan" fname="Natalia" mname="V" lname="Popova" email="popovan@ncbi.nlm.nih.gov"><Role>PHENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="0014190168" aid="1" auth="cit" login="sharopon" fname="Nataliya" mname="Rashidovna" lname="Sharopova" email="sharopon@ncbi.nlm.nih.gov"><Role>GENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="2001203526" aid="1" auth="cit" login="cagaananef" fname="Emilie" mname="Charlisse F" lname="Caga-Anan" email="charlisse.caga-anan@nih.gov"><Role>GPA</Role><Organization>NIH</Organization></Person></Persons></Authority><Policy display-research-statement="true" display-public-summary="true" years-until-renewal="1" weeks-to-cancel-request="8" pub-embargo="none"><acknowledgement_statement>This work was a collaboration of the Broad Institute in Cambridge, MA and the National  Institute of Genomic Medicine (INMEGEN) in Mexico City, Mexico. The work was conducted as part of the Slim Initiative for Genomic Medicine, a project funded by the Carlos Slim  Health Institute in Mexico. The authors request that publications resulting from these data cite the original publication: Banerji, Cibulskis, Rangel-Escareno et al. submitted to Nature.  </acknowledgement_statement><ic_specific_access_term/><DUC universal_duc="Yes"><File full_url="https://dbgap.ncbi.nlm.nih.gov/aa/docs/Static_DUC_20190419.pdf" filename="Static_DUC_20190419.pdf" content-type="application/pdf"/></DUC><DUC_PDF universal_duc="Yes"><File full_url="https://dbgap.ncbi.nlm.nih.gov/aa/docs/Static_DUC_20190419.pdf" filename="Static_DUC_20190419.pdf" content-type="application/pdf"/></DUC_PDF><GSR_Access gsr_mode="unrest_access_by_timeout" gsr_mode_label="Unrestricted access (institution did not respond within six months)"/><ConsentGroup uid="491" CGType="" title="General Research Use" name="GRU" dac_uid="59" dac_name="NCI DAC" irb-approval-required="No"><Use-Restriction>Use of the dataset is limited to research purposes only.
</Use-Restriction></ConsentGroup><ConsentGroup uid="492" CGType="" title="Cancer Research and General Methods" name="CRGM" dac_uid="59" dac_name="NCI DAC" irb-approval-required="No"><Use-Restriction>Use of the data is limited to scientific research relevant to the etiology, prevention, treatment, and late complications of treatment of cancer and for the development of applications proposing analytical methods, software, or other research tools.
</Use-Restriction></ConsentGroup></Policy><SRA/><Documents/><Status uid="1" name="released" title="Released"/></Study></dbgapss>